Ted W. Love - 08 May 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Ted W. Love
Issuer symbol
GILD
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
09 May 2024, 17:30:52 UTC
Previous filing
06 Feb 2024
Next filing
10 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Award $0 +2,310 +451% $0.000000 2,822 08 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +12,648 $0.000000 12,648 08 May 2024 Common Stock 12,648 $64.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,310 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024.
F2 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.